View Future GrowthAehr Test Systems 과거 순이익 실적과거 기준 점검 0/6Aehr Test Systems은 연평균 5.2%의 비율로 수입이 증가해 온 반면, Semiconductor 산업은 연평균 11.2%의 비율로 증가했습니다. 매출은 연평균 13.7%의 비율로 증가했습니다.핵심 정보5.20%순이익 성장률5.45%주당순이익(EPS) 성장률Semiconductor 산업 성장률30.55%매출 성장률13.65%자기자본이익률-8.23%순이익률-25.23%최근 순이익 업데이트27 Feb 2026최근 과거 실적 업데이트Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Mar 30Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Dec 30Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Sep 29Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Jun 30Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Mar 28Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Jan 01모든 업데이트 보기Recent updatesAehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $60 million.Apr 09Aehr Test Systems, Inc. to Report Q3, 2026 Results on Apr 07, 2026Mar 30Aehr Test Systems, Inc. Reinstates Earnings Guidance for the Second Half of Fiscal 2026Jan 09Aehr Test Systems, Inc. to Report Q2, 2026 Results on Jan 08, 2026Dec 30Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025Sep 29Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025Sep 11Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025Jun 30Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025Mar 28Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025Jan 14Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025Jan 01Insufficient new directors Dec 30Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, IncDec 06Investor sentiment deteriorates as stock falls 21% Nov 01Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.Oct 16First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024) Oct 11Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025Oct 11Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024Oct 02Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024Sep 12Investor sentiment improves as stock rises 15% Aug 30Investor sentiment deteriorates as stock falls 21% Aug 06Independent Director recently sold €172k worth of stock Aug 01Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Jul 17+ 1 more updateInvestor sentiment improves as stock rises 39% Jul 12Now 33% overvalued after recent price rise Jul 09Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024Jul 04Now 20% overvalued Jul 01Now 21% overvalued Jun 27Investor sentiment deteriorates as stock falls 15% Jun 26Investor sentiment improves as stock rises 18% Jun 06Insufficient new directors Jun 02Now 27% overvalued Jun 01Now 22% overvalued May 11New major risk - Revenue and earnings growth Apr 12Now 25% overvalued Apr 10Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023) Apr 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Apr 10Investor sentiment deteriorates as stock falls 16% Mar 30Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024Mar 26Investor sentiment deteriorates as stock falls 16% Mar 16Investor sentiment improves as stock rises 17% Feb 09New minor risk - Insider selling Jan 22President recently sold €78k worth of stock Jan 22Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023) Jan 10Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024Jan 10Investor sentiment deteriorates as stock falls 16% Nov 03Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating CommitteeOct 21Investor sentiment deteriorates as stock falls 18% Oct 19First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023) Oct 06Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024Oct 06Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023Sep 27Aehr Test Systems, Annual General Meeting, Oct 23, 2023Sep 14Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022) Aug 30Investor sentiment deteriorates as stock falls 17% Aug 18President recently sold €5.7m worth of stock Jul 21Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022) Jul 14Aehr Test Systems Provides Earnings Guidance for the Year 2024Jul 14Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023Jul 06Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023Jun 01Investor sentiment improves as stock rises 19% May 10Investor sentiment deteriorates as stock falls 21% Apr 25Independent Director recently sold €775k worth of stock Apr 11Investor sentiment deteriorates as stock falls 26% Apr 06Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022) Mar 31Investor sentiment improves as stock rises 33% Mar 09Investor sentiment improves as stock rises 20% Feb 20Insider recently sold €1.2m worth of stock Feb 02Aehr Test Systems Announces Board ChangesJan 28Investor sentiment improves as stock rises 27% Jan 28Independent Director recently sold €381k worth of stock Jan 13Investor sentiment improved over the past week Jan 12Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023Jan 06Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022) Jan 06Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023Dec 23President recently sold €1.7m worth of stock Nov 18Investor sentiment improved over the past week Nov 12Vice President of Engineering recently sold €463k worth of stock Nov 02Investor sentiment improved over the past week Oct 21First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022) Oct 08Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023Oct 07+ 1 more updateInvestor sentiment deteriorated over the past week Sep 28Aehr Test Systems, Annual General Meeting, Oct 18, 2022Sep 24Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022Sep 21Investor sentiment deteriorated over the past week Sep 02Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021) Aug 28Investor sentiment improved over the past week Aug 09Independent Director recently sold €123k worth of stock Aug 05Investor sentiment improved over the past week Jul 26Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021) Jul 21Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023Jul 20Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022Jul 13Investor sentiment improved over the past week Jun 03Investor sentiment improved over the past week May 18Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022Apr 03Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021) Apr 02Aehr Test Systems Reiterates Financial Guidance the Fiscal Year Ending May 31, 2022Apr 01매출 및 비용 세부 내역Aehr Test Systems가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:AYB 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비27 Feb 2645-11171228 Nov 2553-9181229 Aug 2557-7181130 May 2559-4181028 Feb 256123181029 Nov 24512216930 Aug 24592915931 May 24663314929 Feb 24721514930 Nov 23822114931 Aug 23751913831 May 23651512728 Feb 23631412730 Nov 22611211631 Aug 2256911631 May 2251910628 Feb 223849530 Nov 212818531 Aug 2120-17431 May 2117-27428 Feb 2113-56330 Nov 2014-47331 Aug 2019-27331 May 2022-38329 Feb 202608430 Nov 1923-38431 Aug 1922-48431 May 1921-58428 Feb 1921-58430 Nov 1825-28431 Aug 1827-17431 May 183017428 Feb 182907430 Nov 1724-37531 Aug 1721-57531 May 1719-67528 Feb 1714-87430 Nov 1613-87431 Aug 1613-87431 May 1615-77429 Feb 1615-67430 Nov 1515-47431 Aug 1513-57431 May 1510-764양질의 수익: AYB 은(는) 현재 수익성이 없습니다.이익 마진 증가: AYB는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: AYB는 수익성이 없지만 지난 5년 동안 연평균 5.2%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 AYB의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: AYB은 수익성이 없어 지난 해 수익 성장률을 Semiconductor 업계(-24.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: AYB는 현재 수익성이 없으므로 자본 수익률이 음수(-8.23%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSemiconductors 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/03 09:49종가2026/04/30 00:00수익2026/02/27연간 수익2025/05/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Aehr Test Systems, Inc.는 5명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Christian SchwabCraig-Hallum Capital Group LLCEgor TolmachevFreedom BrokerDanial YermakhanFreedom Broker2명의 분석가 더 보기
Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.Jul 17+ 1 more update
Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating CommitteeOct 21
Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023Oct 07+ 1 more update
Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022Apr 03